The fight against cancer demands innovation and collaboration [Video]

The fight against cancer demands innovation and collaboration. In 2021, we joined forces with UCLA to tackle the complexities of Ewing sarcoma and explore more precise immunotherapy options. This journey led to the groundbreaking Universal Cancer Vaccine Platform (UCV), designed to target cancer cells with laser focus while minimizing harm to healthy tissue.

Our commitment to progress didn’t stop there. In 2023, a serendipitous discovery revealed the potential to significantly reduce the cost of CAR-T cell therapy – a powerful but expensive treatment. This birthed the Universal CAR-T Cell Platform, aiming to make this life-saving therapy more accessible.

Today, we stand at the forefront of cancer treatment with three promising projects: Ewing sarcoma research, the targeted UCV platform, and the affordable CAR-T platform. This multi-pronged approach has the potential to redefine the way we fight cancer. We remain dedicated to collaborating with UCLA to translate these innovations into tangible benefits for patients, empowering their bodies’ natural defenses and improving overall outcomes.

Visit us at www.cancervax.com to learn more